1'756 companies found
Aurora Pharma AG
Affoltern Am Albis · Since 1993
The company is a manufacturer of spagyric products, particularly precious stones, metals and plant-based remedies, and also offers services such as contract manufacturing, recipe formulation, product design and label printing for the cosmetics and naturopathy industries. Additionally, it provides further education and online courses on topics such as alchemy and naturopathy.
Bideco AG
Dübendorf · Since 1989
Bideco AG is an engineering and construction firm for biotech and pharmaceutical facilities, focusing on the planning and realisation of production and laboratory sites. It provides comprehensive engineering services as an EPC/EPCM partner, including feasibility studies, conceptual and detailed design, procurement, construction management, commissioning, qualification and GMP consulting.
Bright Peak Therapeutics AG
Allschwil · Since 2017
The core activity of Bright Peak Therapeutics is the development of cancer medications, particularly in the field of immuno-oncology, antibody-drug conjugates (ADCs) and biologics.
Burg Pharma AG
Lucerne · Since 2021
The core activity of Burg Pharma GmbH is the development, manufacture and distribution of infusion solutions and other pharmaceutical products, in particular electrolyte solutions, pediatric solutions, saline solutions, mannitol, carrier solutions, elastomeric pumps, CSTD, Infumix, filling aids, surgical dyes and other medical solutions and devices.
Cantreat AG
Freienbach · Since 2023
The core activity of Cantreat AG is the development and marketing of innovative products for cancer treatment, particularly through the development of nanoparticles for targeted drug delivery in tumor types that are difficult to operate on or where operations have far-reaching consequences for the patient.
Cell Culture Technologies Sagl
Gravesano · Since 2004
Cell Culture Technologies Sagl develops and manufactures custom, chemically defined minimal culture media and related solutions for cell culture. The company also provides technology transfer programs to generate recombinant glycoproteins, monoclonal antibodies, viral particles and cells, and supplies customized formulations for research, development and industrial applications.
Ceres Heilmittel AG
Nax · Since 2011
Ceres Heilmittel AG produces herbal mother tinctures and liquid plant-based medicinal products and markets a compact natural skincare line. The company processes hand-picked organic and biodynamic medicinal plants using a patented mortar mill, matures extracts over time, and operates an academy for health professionals.
Crystal Hemp SA
Lugano · Since 2016
The core activity of Crystal Hemp SA is the development, manufacture and marketing of products based on cannabinoids, in particular CBD products, as well as research and development of medical applications for cannabinoids, including clinical trials.
DEVINTEC Sagl
Lugano · Since 2017
The core activity of Devintec Pharma is the research and development of medical devices and dietary supplements, particularly the development of substance-based medical devices (SMD) using the patented DevinPro technology. This technology enables the creation of a protective, mucus-like barrier that restores the natural and physiological epithelial permeability and allows for the treatment of various diseases. The main therapeutic areas are gastroenterology, dermatology, and gynecology.
Dipharma SA
Chiasso · Since 2014
The core activity of Dipharma SA is the development and manufacturing of high-quality pharmaceuticals, particularly for rare diseases, with a focus on agile processes, transparent partnerships and fair prices.
Dr. F. Messi, cell culture technologies
Gravesano · Since 2005
Dr. F. Messi, cell culture technologies develops and supplies chemically defined and custom-made cell culture media, solutions and technical platforms. The company provides technology transfer programs and services for cultivation, cryopreservation and bioprocess development of mammalian and primary human cells to produce recombinant proteins, monoclonal antibodies and viral particles.
Drossapharm AG
Basel · Since 1972
The core activity of Drossapharm AG is the development, production and marketing of pharmaceuticals, particularly in the fields of rheumatology and orthopedics, as well as the manufacture of active ingredients and the distribution of pharmaceutical products in Switzerland and internationally.
E. Kern AG, pharmazeutische Kräuterspezialitäten
Niederurnen · Since 1966
The core activity of E. Kern AG is the development, manufacture and marketing of pharmaceutical herbal specialties.
emergee sagl
Chiasso · Since 2013
The core activity of emergee is to provide solutions and services for laboratories, particularly in the areas of laboratory analysis, compliance, health, safety and environment (HSE) as well as sustainability. The company offers consulting, training and support to businesses in managing complexity and outsourcing non-core activities.
Ewopharma AG
Schaffhausen · Since 1992
The core activity of Ewopharma is to support pharmaceutical companies as a local partner in their expansion into international markets, particularly in Central and Eastern Europe as well as Switzerland. To this end, Ewopharma offers services such as business development, licensing and marketing for health products, in order to bring them to new markets and improve the quality of life for patients and consumers in these regions.
Frike Pharma AG
Mönchaltorf · Since 2010
Frike Pharma AG is a contract manufacturer for pharmaceutical products, offering formulation development, bulk production, filling and regulatory services.
FRILAB SA
Geneva · Since 2002
FRILAB SA is a pharmaceutical company that markets product lines for family health, gynecology, food supplements and hospital products. It develops products in-house, acquires or licenses medicines and coordinates registration, distribution and pharmacovigilance for international markets.
Gnubiotics Sciences SA
Epalinges · Since 2016
The core activity of Gnubiotics is the development of innovative therapeutics for the treatment of cancer, particularly Immuno-Oncology (I/O) resistant cancer types, through the application of the so-called "Tumor Glycocode" technology. This technology aims to break the tumor glycocode, thereby activating the body's own immune response to combat tumor cells. In this context, the company develops specific glycopeptide formulations, such as GNU101, which promote cytotoxic T-cell activity in the tumor and can be used as biomarkers in diseases such as colorectal cancer.
Grand Medical Group AG
Lausanne · Since 2012
The core activity of Grand Medical Group AG is the development, production, registration and introduction of modern, innovative pharmaceutical products based on organic, synthetic and plant-based compounds. The company is active in all stages of the pharmaceutical business, including research and development, production, registration, distribution and marketing of medicines and health supplements.
Gynial AG
Rotkreuz · Since 2015
GYNIAL is a family-owned pharmaceutical company that is 100% specialized in women's health and gynecology. The company's core activity lies in the development, manufacture and marketing of products for women's health, particularly in the areas of contraception, sexuality and intimate health. The company offers both over-the-counter and prescription products and works closely with experts and partner companies to develop innovative solutions.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register